A company that's balance sheet was struggling and rather dependent on another capital raise or some partnership, gets $110 million USD from a specialist orthopedic fund out of the blue. How is that not positive news?
It seems the market agrees with you however, that makes me worry that many holders really were not aware of the pressing issues highlighted by PwC and the AFR well after the event, that frankly my mother, with a quick squiz of their balance sheet, could have seen.
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group, page-100
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.025(2.28%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.08 | $2.965M | 2.690M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 49545 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 19425 | 8 |
View Market Depth
| Last trade - 12.43pm 10/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |